Virus Supply Vexes Gene Therapy Developers, CMOs
Some Contract Manufacturing Organizations Are Ramping Up Capacity in Preparation for a Boom in Viral Vector Demand
Turning Cell Signaling against Cancer
Researchers Use Single-Molecule Assays, Splice-Switching Oligonucleotides, and Fusion Constructs
Ovarian Cancer Stem Cells: Unraveling a Germline Connection
Stem Cells, the Holy Grail for Tissue Regeneration and Repair, Remain an Elusive Phenomenon in Ovarian Biology
Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients
Gene Therapy Allows Hemophilia Patients to Give Up Medication, Avoid Bleeds; but More Improvements Are Needed
For full access to this article login to GEN Select now.
Myths about Doing Business in China
This Large and Growing Country Provides Many Opportunities for Companies in the Know
- China is growing fast, along with demands for Western products. Since 2000, U.S. exports to China have grown 468%. At $92 billion in 2010, China is now America’s third largest export market. General Motors held its first board of directors meeting in China in 2011. The company sold ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.